Despite the rumbles of discontent surrounding the usefulness of genome-wide association studies, Nick Martin is convinced they remain a useful tool for understanding complex traits and diseases. [ + ]

There will be an increasing demand for temporary workers in the scientific industry, according to Kelly Scientific Resources.

The appearance of a new mutant of bird flu in Asia raises the concern that it might hybridise with swine flu creating a new pandemic threat. [ + ]

Phase I/IIa human trials for Immuron’s (ASX:IMC) IMM 255 immunotherapy for influenza will take place in Israel. [ + ]

The Center for Proteomics at the Translational Genomics Research Institute is selected as a Waters Center of Innovation and recognises Dr Konstantinos Petritis and his team for research excellence.

Part two of our feature on the genetics of modern cotton explores its fascinating evolutionary past, and how it was shaped by human cultivation. [ + ]

The R&D tax credit has been passed in Parliament to help businesses in every sector of the Australian economy transform and invest in the future.

QRxPharma (ASX:QRX) has completed its New Drug Application submission with the FDA, one of the last hurdles before being given regulatory approval. [ + ]

A bold new experiment has shown that controlled release of mosquitoes carrying a bacteria that prevents infection by dengue fever can be an effective control of the widespread disease. [ + ]

Professor Jonathan Wendel is retracing the genetic changes to cotton that have occurred over more than 5000 years of domestication. [ + ]

The Australian Innovation Challenge is now open to both individuals and teams in a range of professional categories and one general public category.

The much-debated and long-delayed R&D Tax Credit has been given the go-ahead by the Senate, although it still needs to go through the House of Representatives for any amendments. [ + ]

Fossils discovered in Western Australia show life in its earliest form: primitive sulphur-eating bacteria that lived 3.4 billion years ago. [ + ]

Living Cell Technologies has begun a trial of its xenotransplantation therapy for the treatment of Type 1 diabetes in Argentina. [ + ]

Renowned earthquake engineer's passing a great loss to science community.